Obesity - An epidemic of the twenty-first century: An update for psychiatrists

Journal of Psychopharmacology

Volumn 19, Issue 6 SUPPL., 2005, Pages 6-15

  Holt, Richard I G ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Diet; Epidemiology; Obesity; Treatment

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; AMFEBUTAMONE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; ANTICONVULSIVE AGENT; BENZOCAINE; BROMOCRIPTINE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CITRIC ACID; ENZYME INHIBITOR; EPHEDRA EXTRACT; MOOD STABILIZER; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; ORAL ANTIDIABETIC AGENT; PSEUDOEPHEDRINE; RIMONABANT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN; THREACHLOROCITRIC ACID; TOPIRAMATE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL LIPASE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; YOHIMBINE;

ANXIETY DISORDER; BARIATRIC SURGERY; BODY MASS; BODY WEIGHT; DEPRESSION; DIET THERAPY; DIETARY INTAKE; DISEASE ASSOCIATION; EPIDEMIC; EXERCISE; FECES INCONTINENCE; GASTROINTESTINAL SYMPTOM; GOAL ATTAINMENT; HEALTH CARE POLICY; HUMAN; KINESIOTHERAPY; LIFESTYLE; LIPID ABSORPTION; MALABSORPTION; MORBIDITY; MORTALITY; NAUSEA; OBESITY; PATHOGENESIS; PATIENT SELECTION; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH SERVICE; REVIEW; SIDE EFFECT; STEATORRHEA; VITAMIN DEFICIENCY; WEIGHT GAIN; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; BARIATRIC SURGERY; BODY MASS INDEX; DIET; DISEASE OUTBREAKS; EXERCISE; FEEDING BEHAVIOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE STYLE; OBESITY; PATIENT SELECTION; PREVALENCE; PSYCHIATRY; RECURRENCE; RISK FACTORS; RISK REDUCTION BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 33749037492     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881105058377     Document Type: Review

References (82)

1. Allison D B, Kaprio J, Korkeila M, Koskenvuo M, Neale M C, Hayakawa K (1996) The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Disord 20: 501-506
2. Anghelescu I, Klawe C, Benkert O (2000) Orlistat in the treatment of psychopharmacologically induced weight gain. J Clin Psychopharmacol 20: 716-717
3. Avenell A, Brown T J, McGee M A, Campbell M K, Grant A M, Broom J, Jung R T, Smith WC (2004a) What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet 17: 317-335
4. Avenell A, Brown T J, McGee M A, Campbell M K, Grant A M, Broom J, Jung R T, Smith WC (2004b) What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions. J Hum Nutr Diet 17: 293-316
5. Bellisle F, Dalix A M (2001) Cognitive restraint can be offset by distraction, leading to increased meal intake in women. Am J Clin Nutr 74: 197-200
6. Blundell J E, Finlayson G (2004) Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption? Physiol Behav 82: 21-25
7. Blundell J E, Gillett A (2001) Control of food intake in the obese. Obes Res 9 (Suppl 4): 263S-270S
8. Bouchard C (1996) Can obesity be prevented? Nutr Rev 54: S125-130.
9. Brownell K D, Kramer F M (1989) Behavioral management of obesity. Med Clin North Am 73: 185-201
10. Caspersen C J, Powell K E, Christenson G M (1985) Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 100: 126-131
11. Cleland J G, Ghosh J, Freemantle N, Kaye G C, Nasir M, Clark A L, Coletta A P (2004) Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail 6: 501-508
12. Colditz G A, Willett W C, Rotnitzky A, Manson J E (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Int Med 122: 481-486
13. Coon K A, Goldberg J, Rogers B L, Tucker K L (2001) Relationships between use of television during meals and children's food consumption patterns. Pediatrics 107: E7
14. Dansinger M L, Gleason J A, Griffith J L, Selker H P, Schaefer E J (2005) Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 293: 43-53
15. Diliberti N, Bordi P L, Conklin M T, Roe L S, Rolls B J (2004) Increased portion size leads to increased energy intake in a restaurant meal. Obes Res 12: 562-568
16. Dursun S M, Devarajan S (2000) Clozapine weight gain, plus topiramate weight loss. Can J Psychiatry 45: 198
17. Fentem P, Walker A (1995). Setting targets for England: challenging, measurable and achievable. In Killoran A J, Fentem P, Caspersen C J (eds), Moving On: International Perspectives on Promoting Physical Activity. Health Education Authority, London
18. Ferchak C V, Meneghini L F (2004) Obesity, bariatric surgery and type 2 diabetes - a systematic review. Diabetes Metab Res Rev 20: 438-445
19. Fernandez J R, Allison D B (2004) Rimonabant Sanofi-Synthelabo. Curr Opin Investig Drugs 5: 430-435
20. Fox K R (2004) Childhood obesity and the role of physical activity. J R Soc Health 124: 34-39
21. Frank E (2004) Physician health and patient care. JAMA 291: 637
22. Goldstein D J (1992) Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 16: 397-415
23. Gortmaker S L, Must A, Perrin J M, Sobol A M, Dietz W H (1993) Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 329: 1008-1012
24. Halford J C (2004) Clinical pharmacotherapy for obesity: current drugs and those in advanced development. Curr Drug Targets 5: 637-646
25. Hanefeld M, Sachse G (2002) The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial. Diabetes Obes Metab 4: 415-423
26. Heini A F, Weinsier R L (1997) Divergent trends in obesity and fat intake patterns: the American paradox. Am J Med 102: 259-264
27. Heshka S, Anderson J W, Atkinson R L, Greenway F L, Hill J O, Phinney S D, Kolotkin R L, Miller-Kovach K, Pi-Sunyer F X (2003) Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA 289: 1792-1798
28. Hilger E, Quiner S, Ginzel I, Walter H, Saria L, Barnas C (2002) The effect of orlistat on plasma levels of psychotropic drugs in patients with long-term psychopharmacotherapy. J Clin Psychopharmacol 22: 68-70
29. James P T, Rigby N, Leach R (2004) The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 11: 3-8
30. James P T, Leach R, Kalamara E, Shayeghi M (2001) The worldwide obesity epidemic. Obes Res 9 Suppl 4: 228S-233S
31. Jarrett R J, Shipley M J, Rose G (1982) Weight and mortality in the Whitehall Study. BMJ 285: 535-537
32. Jeffery R W, Wing R R, Mayer R R (1998) Are smaller weight losses or more achievable weight loss goals better in the long term for obese patients? J Consult Clin Psychol 66: 641-645
33. Jeffery R W, Gray C W, French S A, Hellerstedt W L, Murray D, Luepker R V, Blackburn H (1995) Evaluation of weight reduction in a community intervention for cardiovascular disease risk: changes in body mass index in the Minnesota Heart Health Program. Int J Obes Relat Metab Disord 19: 30-39
34. King A C, Tribble D L (1991) The role of exercise in weight regulation in nonathletes. Sports Med 11: 331-349
35. Lahti-Koski M, Pietinen P, Heliovaara M, Vartiainen E (2002) Associations of body mass index and obesity with physical activity, food choices, alcohol intake, and smoking in the 1982-1997 FINRISK Studies. Am J Clin Nutr 75: 809-817
36. Lean M E (2000a) Obesity: Burdens of illness and strategies for prevention or management. Drugs Today (Barc) 36: 773-784
37. Lean M E (2000b) Is long-term weight loss possible? Br J Nutr 83 (Suppl 1): S103-111
38. Lean M E, Han T S, Morrison C E (1995) Waist circumference as a measure for indicating need for weight management. BMJ 311: 158-161
39. Lean M E, Han T S, Seidell J C (1998) Impairment of health and quality of life in people with large waist circumference. Lancet 351: 853-856
40. Lee I M, Manson J E, Hennekens C H, Paffenbarger R S, Jr (1993) Body weight and mortality. A 27-year follow-up of middle-aged men. JAMA 270: 2823-2828
41. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Despres J P (2000) Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102: 179-184
42. Lessig M C, Shapira N A, Murphy T K (2001) Topiramate for reversing atypical antipsychotic weight gain. J Am Acad Child Adolesc Psychiatry 40: 1364
43. Levy E, Margolese H C, Chouinard G (2002) Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia. J Clin Psychiatry 63: 1045
44. Lissner L, Heitmann B L (1995) Dietary fat and obesity: evidence from epidemiology. Eur J Clin Nutr 49: 79-90
45. McKeigue P M, Shall B, Marmotmg (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337: 382-386
46. Manson J E, Colditz G A, Stampfer M J, Willett W C, Rosner B, Monson R R, Speizer F E, Hennekens C H (1990) A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 322: 882-889
47. Meade T W, Ruddock V, Stirling Y, Chakrabarti R, Miller G J (1993) Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 342: 1076-1079
48. Meltzer H Y, Arvanitis L, Bauer D, Rein W (2004) Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. Am J Psychiatry 161: 975-984
49. Mokdad A H, Serdula M K, Dietz W H, Bowman B A, Marks J S, Koplan J P (2000) The continuing epidemic of obesity in the United States. JAMA 284: 1650-1651
50. National Audit Office (2001) Tackling Obesity in England. The Stationery Office, London
51. National Center for Chronic Disease Prevention and Health Promotion (2005) US Obesity trends 1985-2003. http://www.cdc.gov/nccdphp/ dnpa/obesity/trend/maps/
52. Norris S, Zhang X, Avenell A, Gregg E, Schmid C, Lau J (2005) Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane Database Syst Rev, CD004096
53. O'Rahilly S, Farooqi I S, Yeo G S, Challis B G (2003) Minireview: human obesity-lessons from monogenic disorders. Endocrinology 144: 3757-3764
54. Poirier P, Despres J P (2001) Exercise in weight management of obesity. Cardiol Clin 19: 459-470
55. Prentice A M, Jebb S A (1995) Obesity in Britain: gluttony or sloth? BMJ 311: 437-439
56. Prentice A M, Jebb S A (2001) Beyond body mass index. Obes Rev 2: 141-147
57. Prentice A, Jebb S, Blaskett A, Corner A (2004) A patient support programme for orlistat - analysis of adherence and weight loss. Int J Obes Rel Metab Disord 28 (Suppl 1): S28
58. Raben A, Vasilaras T H, Moller A C, Astrup A (2002) Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr 76: 721-729
59. Rennie K L, Jebb S A (2005) Prevalence of obesity in Great Britain. Obes Rev 6: 11-12
60. Rolls B J, Roe L S, Meengs J S (2004a) Salad and satiety: energy density and portion size of a first-course salad affect energy intake at lunch. J Am Diet Assoc 104: 1570-1576
61. Rolls B J, Roe L S, Kral T V, Meengs J S, Wall D E (2004b) Increasing the portion size of a packaged snack increases energy intake in men and women. Appetite 42: 63-69
62. Rossner S (1993). Is obesity incurable? In Ditschuneit H, Gries F A, Hauner H (eds), Obesity in Europe 1993. John Libbey & Co, London
63. Schulz L O, Schoeller D A (1994) A compilation of total daily energy expenditures and body weights in healthy adults. Am J Clin Nutr 60: 676-681
64. Schwartz T L, Jindal S, Simionescu M, Nihalani N, Azhar N, Tirmazi S, Hussein J (2004) Effectiveness of orlistat versus diet and exercise for weight gain associated with antidepressant use: a pilot study. J Clin Psychopharmacol 24: 555-556
65. Shimokata H, Tobin J D, Muller D C, Elahi D, Coon P J, Andres R (1989) Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol 44: M66-73
66. Silventoinen K, Sans S, Tolonen H, Monterde D, Kuulasmaa K, Kesteloot H, Tuomilehto J (2004) Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord 28: 710-718
67. Sjostrom L, Lindroos A K, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom C D, Sullivan M, Wedel H (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351: 2683-2693
68. Sonne-Holm S, Sorensen T I (1986) Prospective study of attainment of social class of severely obese subjects in relation to parental social class, intelligence, and education. BMJ 292: 586-589
69. Stubbs R J, Harbron C G, Murgatroyd P R, Prentice A M (1995) Covert manipulation of dietary fat and energy density: effect on substrate flux and food intake in men eating ad libitum. Am J Clin Nutr 62: 316-329
70. Teixeira P J, Going S B, Sardinha L B, Lohman T G (2005) A review of psychosocial pre-treatment predictors of weight control. Obes Rev 6: 43-65
71. Torgerson J S, Hauptman J, Boldrin M N, Sjostrom L (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27: 155-161
72. Tsai A G, Wadden T A (2005) Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med 142: 56-66
73. US Department of Health and Human Services (1996) Physical Activity and health. A report of the Surgeon General (Executive Summary). Superintendeny of Documents, Pittsburgh, PA
74. Van Pelt R E, Evans E M, Schechtman K B, Ehsani A A, Kohrt W M (2001) Waist circumference vs body mass index for prediction of disease risk in postmenopausal women. Int J Obes Relat Metab Disord 25: 1183-1188
75. Visscher T L, Seidell J C (2001) The public health impact of obesity. Ann Rev Public Health 22: 355-375
76. Wadden T A, Stunkard A J (1985) Social and psychological consequences of obesity. Ann Intern Med 103: 1062-1067
77. Wadden T A, Butryn M L, Byrne K J (2004) Efficacy of lifestyle modification for long-term weight control. Obes Res 12 (Suppl): 151S-162S
78. Wadden T A, Steen S N, Wingate B J, Foster G D (1996) Psychosocial consequences of weight reduction: how much weight loss is enough? Am J Clin Nutr 63: 461S-465S
79. WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163
80. Wilkin T J, Choquet R C, Schmouker Y, Rouquette N, Baldet L, Vannereau D (1983) Maximum calorie (sub-threshold) dieting of the obese and its hormonal response. Acta Endocrinol 103: 184-187
81. World Health Organisation (1997) Obesity: preventing and managing the global epidemic. WHO, Geneva
82. Wynne K, Stanley S, Bloom S (2004) The gut and regulation of body weight. J Clin Endocrinol Metab 89: 2576-2582